Biotech · Private company
Padagis LLC
Track this companyFree. Adds Padagis LLC to your Dealase workspace and tells you when its record changes.
Clinical trials170 recruiting or active
Pipeline programs28From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline28
- Acyclovir 5 percent (Perrigo)Phase 3 · Herpes LabialisClinicalTrials.gov · fetched Nov 12, 2026
- Acyclovir 5 percent (Reference)Phase 3 · Herpes LabialisClinicalTrials.gov · fetched Nov 12, 2026
- Adapalene and Benzoyl Peroxide Topical GelPhase 3 · Acne VulgarisClinicalTrials.gov · fetched Nov 12, 2026
- Azelaic acid foamPhase 3 · RosaceaClinicalTrials.gov · fetched Nov 12, 2026
- Azelastine Hydrochloride/Fluticasone Propionate Nasal SprayPhase 3 · Seasonal Allergic RhinitisClinicalTrials.gov · fetched Nov 12, 2026
- Azopt 1% Ophthalmic SuspensionPhase 3 · Glaucoma, Open-AngleClinicalTrials.gov · fetched Nov 12, 2026
- Brinzolamide 1% ophthalmic suspensionPhase 3 · Glaucoma, Open-AngleClinicalTrials.gov · fetched Nov 12, 2026
- Brinzolamide/brimonidine ophthalmic suspensionPhase 3 · Glaucoma, Open-AngleClinicalTrials.gov · fetched Nov 12, 2026
- Clindamycin and Benzoyl Peroxide Gel (combination)Phase 3 · AcneClinicalTrials.gov · fetched Nov 12, 2026
- Clindamycin and Benzoyl Peroxide Gel (Reference) (combination)Phase 3 · AcneClinicalTrials.gov · fetched Nov 12, 2026
- EntocortPhase 3 · Crohn's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Epiduo Topical ProductPhase 3 · Acne VulgarisClinicalTrials.gov · fetched Nov 12, 2026
- estrace cream (Perrigo)Phase 3 · AtrophyClinicalTrials.gov · fetched Nov 12, 2026
- estrace cream (Reference)Phase 3 · AtrophyClinicalTrials.gov · fetched Nov 12, 2026
- Mometasone furoatePhase 3 · Seasonal Allergic RhinitisClinicalTrials.gov · fetched Nov 12, 2026
- Mupirocin CalciumPhase 3 · Secondarily Infected Traumatic Skin LesionsClinicalTrials.gov · fetched Nov 12, 2026
- Nasonex Nasal SprayPhase 3 · Seasonal Allergic RhinitisClinicalTrials.gov · fetched Nov 12, 2026
- OxymetazolinePhase 3 · RosaceaClinicalTrials.gov · fetched Nov 12, 2026
- roflumilast cream 0.3%Phase 3 · Plaque PsoriasisClinicalTrials.gov · fetched Nov 12, 2026
- Simbrinza 0.2%/1% Ophthalmic SuspensionPhase 3 · Glaucoma, Open-AngleClinicalTrials.gov · fetched Nov 12, 2026
- VehiclePhase 3 · Secondarily Infected Traumatic Skin LesionsClinicalTrials.gov · fetched Nov 12, 2026
- ZoryvePhase 3 · Plaque PsoriasisClinicalTrials.gov · fetched Nov 12, 2026
- Compazine® suppositories, 25mgPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- Flavoxate Hydrochloride Tablets, 100mgPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- Prochlorperazine suppositories, 25mgPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- Urispas® Tablets, 100mgPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- Butoconazole Nitrate Vaginal CreamVulvovaginal CandidiasisClinicalTrials.gov · fetched Nov 12, 2026
- Gynazole 1 vaginal creamVulvovaginal CandidiasisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials17
- Bioequivalence Study of Two Treatments for the Treatment of Plaque PsoriasisPHASE3 · COMPLETED · started Feb 7, 2023ClinicalTrials.gov NCT05763082 · fetched Nov 12, 2026
- To Compare the Efficacy and Safety of Perrigo's Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in Both EyesPHASE3 · COMPLETED · started May 28, 2021ClinicalTrials.gov NCT04944290 · fetched Nov 12, 2026
- To Compare the Safety and Efficacy of Perrigo's Product to an FDA Approved Product for the Treatment of Secondarily Infected Traumatic Skin LesionsPHASE3 · COMPLETED · started Oct 15, 2019ClinicalTrials.gov NCT04155203 · fetched Nov 12, 2026
- To Compare the Safety and Efficacy of Perrigo's Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in Both EyesPHASE3 · COMPLETED · started Jun 24, 2019ClinicalTrials.gov NCT04024072 · fetched Nov 12, 2026
- Bioequivalence Study of Two Treatments in the Treatment of Acne Vulgaris on the FacePHASE3 · COMPLETED · started Dec 13, 2017ClinicalTrials.gov NCT03393494 · fetched Nov 12, 2026
- An Evaluation of the Reduction in Erythema in Adult Patients With Moderate to Severe Persistent Facial Erythema Associated With RosaceaPHASE3 · COMPLETED · started Oct 18, 2017ClinicalTrials.gov NCT03352323 · fetched Nov 12, 2026
- Bioequivalence Study of Two Treatments in the Treatment of Inflammatory Lesions of Rosacea on the FacePHASE3 · COMPLETED · started Nov 1, 2016ClinicalTrials.gov NCT02800148 · fetched Nov 12, 2026
- Comparative Safety and Efficacy of Two Treatments in the Treatment of Vulvar and Vaginal AtrophyPHASE3 · COMPLETED · started May 1, 2016ClinicalTrials.gov NCT02770365 · fetched Nov 12, 2026
- Comparative Safety and Efficacy of Two Treatments in the Treatment of Acne VulgarisPHASE3 · COMPLETED · started Jul 1, 2015ClinicalTrials.gov NCT02515305 · fetched Nov 12, 2026
- Comparative Safety and Efficacy of Two Antiviral Treatments in the Treatment of Recurrent Herpes Simplex LabialisPHASE3 · COMPLETED · started Oct 6, 2014ClinicalTrials.gov NCT02265913 · fetched Nov 12, 2026
- Comparative Safety and Efficacy of Two Steroid Treatments in the Relief of the Symptoms of Seasonal Allergic RhinitisPHASE3 · COMPLETED · started Aug 1, 2014ClinicalTrials.gov NCT02230696 · fetched Nov 12, 2026
- A Safety and Bioequivalence of a Mometasone Nasal Spray, 50 mcg/Actuation Compared With Nasonex® Nasal Spray 50 mcg/Actuation in the Relief of the Symptoms of Seasonal Allergic Rhinitis (SAR)PHASE3 · COMPLETED · started Aug 1, 2012ClinicalTrials.gov NCT01673659 · fetched Nov 12, 2026
- Safety and Maintenance Study of Entocort for Children With Crohn's DiseasePHASE3 · COMPLETED · started Dec 1, 2011ClinicalTrials.gov NCT01453946 · fetched Nov 12, 2026
- Safety Study of Entocort for Children With Crohn's DiseasePHASE3 · COMPLETED · started Nov 1, 2011ClinicalTrials.gov NCT01444092 · fetched Nov 12, 2026
- A Randomized Study Evaluating the Therapeutic Equivalence of Two Butoconazole Nitrate Vaginal Cream, 2% FormulationsNA · COMPLETED · started Feb 1, 2008ClinicalTrials.gov NCT01039584 · fetched Nov 12, 2026
- A Relative Bioavailability Study of 100 mg Flavoxate Hydrochloride Tablets Under Fasting ConditionsPHASE1 · COMPLETEDClinicalTrials.gov NCT00992238 · fetched Nov 12, 2026
- Bioavailability of Prochlorperazine Suppositories, 25 mgPHASE1 · COMPLETEDClinicalTrials.gov NCT00992472 · fetched Nov 12, 2026